Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brit Mollenhauer

Showing results (11-20 of 328) with videos related to

Pageof 33
Sort By:
Alzheimer'S Research & Therapy|December 6, 2014
Biomarkers in biological fluids for dementia with Lewy bodiesSebastian Schade, Brit Mollenhauer
Nature Reviews. Neurology|April 7, 2021
Prodromal Parkinson disease - time is brainSandrina Weber, Brit Mollenhauer
Journal of Immunological Methods|August 15, 2015
Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluidNiels Kruse, Brit Mollenhauer
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2010
CSF synuclein: adding to the biomarker footprint of dementia with Lewy bodiesBrit Mollenhauer, Michael G Schlossmacher
The Lancet. Neurology|December 20, 2024
Movement disorders in 2024: peripheral and outside the boxBrit Mollenhauer, Chin-Hsien Lin
Biomarkers in Medicine|October 16, 2010
Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trialsMichael G Schlossmacher, Brit Mollenhauer
International Review of Neurobiology|May 31, 2017
Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's DiseaseIskandar Johar, Brit Mollenhauer, Dag Aarsland
Movement Disorders Clinical Practice|April 8, 2020
Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and SafinamideSebastian Schade, Brit Mollenhauer, Claudia Trenkwalder
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2018
The importance of an independent validation cohort for metabolomics biomarker studiesJean-Pierre Trezzi, Karsten Hiller, Brit Mollenhauer
Science (New York, N.Y.)|August 18, 2022
Toward preventing Parkinson's diseaseBrit Mollenhauer, Christine A F von Arnim
Pageof 33

Showing results (11-20 of 328) with videos related to

Sort By:
Pageof 33
Alzheimer'S Research & Therapy|December 6, 2014
Biomarkers in biological fluids for dementia with Lewy bodiesSebastian Schade, Brit Mollenhauer
Nature Reviews. Neurology|April 7, 2021
Prodromal Parkinson disease - time is brainSandrina Weber, Brit Mollenhauer
Journal of Immunological Methods|August 15, 2015
Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluidNiels Kruse, Brit Mollenhauer
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2010
CSF synuclein: adding to the biomarker footprint of dementia with Lewy bodiesBrit Mollenhauer, Michael G Schlossmacher
The Lancet. Neurology|December 20, 2024
Movement disorders in 2024: peripheral and outside the boxBrit Mollenhauer, Chin-Hsien Lin
Biomarkers in Medicine|October 16, 2010
Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trialsMichael G Schlossmacher, Brit Mollenhauer
International Review of Neurobiology|May 31, 2017
Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's DiseaseIskandar Johar, Brit Mollenhauer, Dag Aarsland
Movement Disorders Clinical Practice|April 8, 2020
Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and SafinamideSebastian Schade, Brit Mollenhauer, Claudia Trenkwalder
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2018
The importance of an independent validation cohort for metabolomics biomarker studiesJean-Pierre Trezzi, Karsten Hiller, Brit Mollenhauer
Science (New York, N.Y.)|August 18, 2022
Toward preventing Parkinson's diseaseBrit Mollenhauer, Christine A F von Arnim
Pageof 33